Hoertkorn Richard Charles’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-78
Closed -$1.99K 82
2023
Q2
$1.99K Hold
78
﹤0.01% 75
2023
Q1
$2.32K Hold
78
﹤0.01% 75
2022
Q4
$2.11K Hold
78
﹤0.01% 74
2022
Q3
$2K Hold
78
﹤0.01% 73
2022
Q2
$2K Hold
78
﹤0.01% 71
2022
Q1
$3K Hold
78
﹤0.01% 74
2021
Q4
$3K Hold
78
﹤0.01% 77
2021
Q3
$2K Hold
78
﹤0.01% 77
2021
Q2
$3K Hold
78
﹤0.01% 76
2021
Q1
$3K Hold
78
﹤0.01% 79
2020
Q4
$4K Hold
78
﹤0.01% 78
2020
Q3
$3K Hold
78
﹤0.01% 80
2020
Q2
$2K Hold
78
﹤0.01% 82
2020
Q1
$2K Hold
78
﹤0.01% 81
2019
Q4
$3K Hold
78
﹤0.01% 81
2019
Q3
$3K Hold
78
﹤0.01% 86
2019
Q2
$3K Hold
78
﹤0.01% 84
2019
Q1
$3K Hold
78
﹤0.01% 83
2018
Q4
$3K Hold
78
﹤0.01% 83
2018
Q3
$5K Hold
78
﹤0.01% 86
2018
Q2
$4K Hold
78
﹤0.01% 88
2018
Q1
$4K Hold
78
﹤0.01% 89
2017
Q4
$4K Hold
78
﹤0.01% 90
2017
Q3
$4K Hold
78
﹤0.01% 88
2017
Q2
$3K Hold
78
﹤0.01% 85
2017
Q1
$3K Hold
78
﹤0.01% 86
2016
Q4
$3K Hold
78
﹤0.01% 89
2016
Q3
$3K Hold
78
﹤0.01% 90
2016
Q2
$3K Hold
78
﹤0.01% 93
2016
Q1
$2K Hold
78
﹤0.01% 93
2015
Q4
$3K Hold
78
﹤0.01% 98
2015
Q3
$2K Hold
78
﹤0.01% 95
2015
Q2
$3K Hold
78
﹤0.01% 92
2015
Q1
$4K Hold
78
﹤0.01% 94
2014
Q4
$4K Buy
+78
New +$3.06K ﹤0.01% 98

Other funds holding AVNS

Hoertkorn Richard Charles's AVNS Position: Q3 2023 in Review

Hoertkorn Richard Charles sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 78 shares — an estimated $1.99K sold.

Hoertkorn Richard Charles first reported a position in AVNS in Q4 2014 and held it in 35 quarters. The position peaked at $5K in Q3 2018. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • Hoertkorn Richard Charles reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • Hoertkorn Richard Charles sold 78 Avanos Medical shares in Q3 2023, an estimated $1.99K.
  • Hoertkorn Richard Charles first reported a position in Avanos Medical in Q4 2014 and held it in 35 quarters.
  • Hoertkorn Richard Charles's Avanos Medical position peaked at $5K in Q3 2018.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Hoertkorn Richard Charles's 13F filing for Q3 2023, filed 23 Oct 2023.